text_1: India allows limited exports of anti-malaria drug after Trump warns of retaliation.
text_2: India, the world’s main supplier of generic drugs, said on Tuesday it will allow limited exports of the anti-malaria drug hydroxychloroquine that U.S. President Donald Trump has touted as a potential weapon in the fight against the coronavirus.